Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine versus bupivacaine + tramadol wound infiltration for post-cesarean analgesia
PACTR202310525672884Phase 4Not yet recruiting
- Sponsor
- Dilla University
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Bupivacaine alone with Bupivacaine + tramadol (2 arms). Primary endpoints: Postoperative total analgesia consumption in the first 24 hours, Time to first analgesic request and 1 more. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
bupivacainetramadol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202310525672884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202310525672884.